Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option for patients with malignant- and non-malignant blood disorders. One of the main limitations of this treatment is acute graft-versus-host disease (GvHD), a potentially severe complication in which donor lymphocytes target tissues of the host for destruction. Tissue damage and
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 27 Oct 2023 |
Print ISBNs | 9789083369518 |
Publication status | Published - 2023 |